Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers

NCT03245918 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT03245918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03245918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers
Lead sponsor
The Hospital for Sick Children
Phase
Phase 1
Overall status
Completed
Start date
August 10, 2017
Completion date
January 5, 2018
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting